Form 8K Calidi Biotherapeutics Inc For: 8 May
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Calidi Biotherapeutics Inc (CLDI)
Assess today's live Calidi Biotherapeutics Inc (CLDI) share price, performance and insights using our live NYSE: CLDI stock exchange data.
Analyse the historical data and Calidi Biotherapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Calidi Biotherapeutics share price buy/sell indicators using real-time data (or discuss the Calidi Biotherapeutics (CLDI) stock price today with other investors in the Calidi Biotherapeutics NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE CLDI share price (ISIN: US3207034089) to enhance your trading decisions with our free investment tools and resources.
What Is the Calidi Biotherapeutics Inc Share Price Today?
The Calidi Biotherapeutics share price today is 0.1693.
What Is the Stock Symbol for Calidi Biotherapeutics Inc
The stock symbol (or 'ticker') for Calidi Biotherapeutics Inc is "CLDI."
What Stock Exchange Does Calidi Biotherapeutics Inc Trade On?
Calidi Biotherapeutics Inc is listed and trades on the NYSE stock exchange.
Is Calidi Biotherapeutics Inc a Good Stock to Buy?
Determining whether Calidi Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Calidi Biotherapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Calidi Biotherapeutics share price buy/sell indicators using real-time data (or discuss the Calidi Biotherapeutics (CLDI) stock price today with other investors in the Calidi Biotherapeutics NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE CLDI share price (ISIN: US3207034089) to enhance your trading decisions with our free investment tools and resources.
What Is the Calidi Biotherapeutics Inc Share Price Today?
The Calidi Biotherapeutics share price today is 0.1693.
What Is the Stock Symbol for Calidi Biotherapeutics Inc
The stock symbol (or 'ticker') for Calidi Biotherapeutics Inc is "CLDI."
What Stock Exchange Does Calidi Biotherapeutics Inc Trade On?
Calidi Biotherapeutics Inc is listed and trades on the NYSE stock exchange.
Is Calidi Biotherapeutics Inc a Good Stock to Buy?
Determining whether Calidi Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1650
0.1828
52 wk Range
0.1600
19.2000
CLDI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.16500.1828
52 wk Range
0.160019.2000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLDI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
120.0048
Upside
+70,782.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K Calidi Biotherapeutics Inc For: 8 May
- Investing.com
- Calidi presents cancer therapy data at AACR meeting
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 120.0048
(+70,782.93% Upside)
Earnings
Latest Release
14/05/2026
EPS / Forecast
-0.43 / --
Revenue / Forecast
-- / --
Compare CLDI to Peers and Sector
Metrics to compare | CLDI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLDIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −2.8x | −0.5x | |
PEG Ratio | 0.00 | −0.19 | 0.00 | |
Price/Book | 0.5x | 3.2x | 2.6x | |
Price / LTM Sales | - | 131.7x | 3.1x | |
Upside (Analyst Target) | - | 242.0% | 54.0% | |
Fair Value Upside | Unlock | 18.0% | 6.5% | Unlock |
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as NeuroNova and SuperNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Calidi Biotherapeutics (NYSE: CLDI) Share Price Today?
The Calidi Biotherapeutics stock price today is 0.1693 USD.
What Stock Exchange Does Calidi Biotherapeutics (CLDI) Trade On?
Calidi Biotherapeutics is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for Calidi Biotherapeutics?
The stock symbol (also called a 'ticker') for Calidi Biotherapeutics is "CLDI."
What Is the Current Calidi Biotherapeutics Market Capitalisation?
As of today, Calidi Biotherapeutics (NYSE: CLDI) market cap is 2.8300M USD.
What Is Calidi Biotherapeutics's (CLDI) Earnings Per Share (TTM)?
The Calidi Biotherapeutics EPS is currently -3.9627 (Trailing Twelve Months).
Is CLDI a Buy or Sell From a Technical Analyst Perspective?
Based on today's Calidi Biotherapeutics moving averages and other technical indicators, the daily buy/sell signal for CLDI stock is Strong Sell.
How Many Times Has Calidi Biotherapeutics Stock Split?
Calidi Biotherapeutics has split 2 times. (See the CLDI stock split history page for full effective split date and price information.)
How Many Employees Does Calidi Biotherapeutics Have?
Calidi Biotherapeutics has 29 employees, based on their latest Companies House report.
What is the current trading status of Calidi Biotherapeutics (NYSE: CLDI)?
As of 21/05/2026, Calidi Biotherapeutics (CLDI) is trading at a share price of 0.1693 USD, with a previous close of 0.1693 USD. The stock has fluctuated within a day range of 0.1650 USD to 0.1828 USD, while its 52-week range spans from 0.1600 USD to 19.2000 USD.
What Is Calidi Biotherapeutics (CLDI) Price Target According to Analysts?
The average 12-month price target for Calidi Biotherapeutics is 120.0048 USD, with a high estimate of 120.0048 USD and a low estimate of 120.0048 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +70,782.93% Upside potential.
What Is the CLDI Premarket Price?
CLDI's last pre-market stock price is 0.1735 USD. The pre-market share volume is 206,700.0000, and the stock has decreased by 0.0042, or 2.4800%.
What Is the CLDI After Hours Price?
CLDI's last after hours stock price is 0.1690 USD, the stock has decreased by -0.0003, or -0.1800%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.